Correlation Between Taysha Gene and Candel Therapeutics
Can any of the company-specific risk be diversified away by investing in both Taysha Gene and Candel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Taysha Gene and Candel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Taysha Gene Therapies and Candel Therapeutics, you can compare the effects of market volatilities on Taysha Gene and Candel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Taysha Gene with a short position of Candel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Taysha Gene and Candel Therapeutics.
Diversification Opportunities for Taysha Gene and Candel Therapeutics
-0.11 | Correlation Coefficient |
Good diversification
The 3 months correlation between Taysha and Candel is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Taysha Gene Therapies and Candel Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Candel Therapeutics and Taysha Gene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Taysha Gene Therapies are associated (or correlated) with Candel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Candel Therapeutics has no effect on the direction of Taysha Gene i.e., Taysha Gene and Candel Therapeutics go up and down completely randomly.
Pair Corralation between Taysha Gene and Candel Therapeutics
Given the investment horizon of 90 days Taysha Gene is expected to generate 6.54 times less return on investment than Candel Therapeutics. But when comparing it to its historical volatility, Taysha Gene Therapies is 2.05 times less risky than Candel Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Candel Therapeutics is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest 447.00 in Candel Therapeutics on September 13, 2024 and sell it today you would earn a total of 328.00 from holding Candel Therapeutics or generate 73.38% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Taysha Gene Therapies vs. Candel Therapeutics
Performance |
| Timeline |
| Taysha Gene Therapies |
| Candel Therapeutics |
Taysha Gene and Candel Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Taysha Gene and Candel Therapeutics
The main advantage of trading using opposite Taysha Gene and Candel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Taysha Gene position performs unexpectedly, Candel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Candel Therapeutics will offset losses from the drop in Candel Therapeutics' long position.| Taysha Gene vs. Biomea Fusion | Taysha Gene vs. Stoke Therapeutics | Taysha Gene vs. Akero Therapeutics | Taysha Gene vs. Gossamer Bio |
| Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |